Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6784)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 18, 2015 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nosotti L, Baiocchini A, Bonifati C, Visco-Comandini U, Mirisola C, Del Nonno F. Unusual case of B cell lymphoma after immunosuppressive treatment for psoriasis. World J Hepatol 2015; 7(5): 814-818 [PMID: 25914782 DOI: 10.4254/wjh.v7.i5.814] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i5/814.htm |
| Number | Citing Articles |
| 1 |
Gautham Vellaichamy, Steven M. Townsend, Alexis B. Lyons, Iltefat H. Hamzavi. T-cell/histiocyte-rich large B-cell lymphoma in a 27-year-old with hidradenitis suppurativa, psoriasis, and vitiligo: Implications for screening. JAAD Case Reports 2020; 6(12): 1252 doi: 10.1016/j.jdcr.2020.08.032
|
| 2 |
Ju Yeon Ryoo, Hye-Jin Yang, Eunhee Ji, Bong Kyu Yoo. Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis. Annals of Pharmacotherapy 2016; 50(5): 341 doi: 10.1177/1060028015626545
|
| 3 |
Michihide Tokuhira, Jun-ichi Tamaru, Masahiro Kizaki. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. Journal of Clinical and Experimental Hematopathology 2019; 59(2): 72 doi: 10.3960/jslrt.19007
|
| 4 |
R.P.O.M. Andrade, K.W.P. Gomes, W.P. Vieira, A.J.P. Luz. LINFOMA E ESPONDILITE ANQUILOSANTE (EA) EM USO DE ANTI‐TNF: RELATO DE DOIS CASOS. Revista Brasileira de Reumatologia 2017; 57: S115 doi: 10.1016/j.rbr.2017.07.080
|
| 5 |
Paul Sator. Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience. Therapeutic Advances in Chronic Disease 2018; 9(8): 147 doi: 10.1177/2040622318772705
|